CD90.2 Antibody, anti-mouse, VioBlue®, REAlease®，130-123-066，美天旎

Clone REAL294 is an antibody fragment derived from the full mouse CD90.2 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL294 recognizes the mouse CD90 (Thy1.2) antigen which is expressed at high levels on thymocytes and peripheral T cells in lymphoid organs and blood as well as on retinal ganglion cells. Clone REAL294 reacts with the Thy1.2 alloantigen, which is a pan–T cell marker for the most common inbred mouse strain. These strains include BALB/c, DBA, CBA/J, C3H, C57BL/6, NZB/-, S3L and others. It does not cross-react with Thy1.1. CD90 is also expressed at lower levels on early hematopoietic stem cells in the bone marrow, on interepithelial cells (dendritic epidermal T cells) in skin, and on neurons.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

THY1, T25, Thy-1, Thy-1.2

Technical specifications